Screening tool for minimal hepatic encephalopathy
Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.
This study tests a new cognitive tool to quickly and reliably detect minimal hepatic encephalopathy, a subtle brain change that can occur in people with liver disease. If you have a liver condition like fibrosis or cirrhosis and are already scheduled for a full evaluation (neuropsychological tests, MRI, EEG, and blood ammonia), this tool could help simplify future screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have a liver problem (such as fibrosis, cirrhosis, or an abnormal connection between the portal vein and systemic veins)
- You are already set to have a complete check-up at the BLIPS clinic (including a thinking test, MRI, EEG, and a blood ammonia test)
- You agree to take part in the study
- You are covered by the French healthcare system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests quick new methods to measure “slowed actions” in people with stroke or memory-related brain conditions. The goal is to see whether these quick tests can help predict future outcomes and guide care.
This study aims to validate a digital cognitive assessment tool (Neuralix) for people who have experienced moderate to severe head trauma within the past 5 years. Participation helps ensure the tool is accurate and useful for monitoring recovery.
This trial checks a new kind of paper-and-pen (or computer-based) test to better measure thinking and social/behavior skills in people with certain brain diseases. It may help researchers improve how these skills are tracked and understood over time.
This study uses a set of paper-and-pencil thinking tests (called PHES) to detect a mild form of brain fog that can occur with cirrhosis, known as minimal hepatic encephalopathy. The goal is to help doctors identify this early so it can be managed before it becomes more serious.
This study compares using an electronic version of a short thinking test with a traditional paper test to diagnose hepatic encephalopathy, a brain condition caused by liver disease. It aims to make diagnosis easier and more accurate for patients with cirrhosis.
This study looks at how well simple brain tests can detect early (minimal) thinking changes related to liver cirrhosis. It may help doctors spot these changes sooner and diagnose the condition more accurately.
Hear when a new Hepatic Pathology (Fibrosis, Cirrhosis, Porto Systemic Shunts) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.